Summary: For children and adolescents, avoiding use of selective serotonin and serotonin-norepinephrine reuptake inhibitor antidepressants (specifically, duloxetine, fluoxetine, paroxetine, sertraline, or venlafaxine) may be associated with a lower risk of adverse outcomes (specifically, suicidality or aggression) compared to treatment with these antidepressants.

http://www.ncbi.nlm.nih.gov/m/pubmed/26819231/

Strength of Recommendation = A

Advertisements